Lee SY, Choe YS, Ryu EK, Iimura Y, Choi Y, Lee KH, Kim BT (2006) <br />Is subnanomolar binding affinity required for the in vivo imaging of acetylcholinesterase? Studies on 18F-labeled G379<br /><i>Nucl Med Biol</i> <b>33</b>: 91<br /><br />Sugimoto H, Iimura Y, Kawakami Y, Yamanishi Y (2000) <br />Donepezil Hydrochloride (E2020) and Other Acetylcholinesterase Inhibitors<br /><i>Curr Med Chem</i> <b>7</b>: 303<br /><br />Sugimoto H, Yamanishi Y, Ogura H, Iimura Y, Yamatsu K (1999) <br />[Discovery and development of donepezil hydrochloride for the treatment of Alzheimer's disease]<br /><i>Yakugaku Zasshi</i> <b>119</b>: 101<br /><br />Inoue A, Kawai T, Wakita M, Iimura Y, Sugimoto H, Kawakami Y (1996) <br />The simulated binding of (+/-)-2,3-dihydro-5,6-dimethoxy-2-[[1-(phenylmethyl)-4-piperidinyl]m eth yl] -1H-inden-1-one hydrochloride (E2020) and related inhibitors to free and acylated acetylcholinesterases and corresponding structure-activity analyses<br /><i>Journal of Medicinal Chemistry</i> <b>39</b>: 4460<br /><br />Sugimoto H, Iimura Y, Yamanishi Y, Yamatsu K (1995) <br />Synthesis and structure-activity relationships of acetylcholinesterase inhibitors: 1-benzyl-4-[(5,6-dimethoxy-1-oxoindan-2- yl)methyl]piperidine hydrochloride and related compounds<br /><i>Journal of Medicinal Chemistry</i> <b>38</b>: 4821<br /><br />Sugimoto H, Tsuchiya Y, Sugumi H, Higurashi K, Karibe N, Iimura Y, Sasaki A, Araki S, Yamanishi Y, Yamatsu K (1992) <br />Synthesis and structure-activity relationships of acetylcholinesterase inhibitors: 1-benzyl-4-(2-phthalimidoethyl)piperidine and related derivatives<br /><i>Journal of Medicinal Chemistry</i> <b>35</b>: 4542<br /><br />Sugimoto H, Tsuchiya Y, Sugumi H, Higurashi K, Karibe N, Iimura Y, Sasaki A, Kawakami Y, Nakamura T, Araki S, Yamanishi Y, Yamatsu K (1990) <br />Novel piperidine derivatives. Synthesis and anti-acetylcholinesterase activity of 1-benzyl-4-[2-(N-benzoylamino)ethyl]piperidine derivatives<br /><i>Journal of Medicinal Chemistry</i> <b>33</b>: 1880<br /><br />